Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
Biopharmaceutics and Drug Disposition(1)
Biotecnologia Aplicada(1)
European Journal of Pharmaceutical Sciences(1)
Pharmacogenomics(1)
Área temáticas
Farmacología y terapéutica(2)
Enfermedades(1)
Fisiología humana(1)
Funcionamiento de bibliotecas y archivos(1)
Medicina y salud(1)
Origen
scopus(4)
Integrated pharmacokinetic-pharmacodynamic modeling and allometric scaling for optimizing the dosage regimen of the monoclonal ior EGF/r3 antibody
ArticleAbstract: The multiple-dose strategy with the monoclonal ior EGF/r3 antibody, in xenograft bearing nude mice,Palabras claves:Allometric scaling, Dosage regimen, Integrated pharmacokinetic-pharmacodynamic, Monoclonal antibody ior EGF/r3, Survival time, Tumor growth delayAutores:Alonso K., Alvarez D., Beausoleil I., Bécquer M.d.l.A., Castillo R., Duconge J., Fernández-Sánchez E.M., Matheu J., Tania Crombet, Valenzuela-Silva C.M., Vecino G.Fuentes:scopusPharmacogenetic research activity in Central America and the Caribbean: A systematic review
ReviewAbstract: Aim: The present review was aimed at analyzing the pharmacogenetic scientific activity in Central AmPalabras claves:Biomarkers, Caribbean Region, Central America, pharmacogenetics, PharmacogenomicsAutores:Adrián LLerena, Campos M.D.L.A., Céspedes-Garro C., Duconge J., Humberto Fariñas, Montané-Jaime L.K., Naranjo M.E.G., Penãs-Lledó E.M., Ramirez R., Roblejo H., Rodrigues-Soares F., Serrano V., Villagrán C.I.Fuentes:scopusThe role of Pharmacometrics in the development of Cuban Biotechnology products
ArticleAbstract: Pharmacometrics is a vibrant scientific discipline that involves a cycle of excellence: integration,Palabras claves:nimotuzumab, NONMEM, Pegylated erythropoietin, pharmacodynamics, pharmacokinetics, PharmacometricsAutores:Amaro D., Bécquer M.d.l.A., Carmen Elena Viada, Castañeda G., Colom H., de Castro Suárez N., Duconge J., Fernández G.R., Fernández-Sánchez E.M., Menéndez R., Sanjuan V.M., Solazábal J., Suzarte M.R., Vélez B.J., Vera L.R.Fuentes:scopusTopical disposition of two strengths of a <sup>125</sup>I-rhEGF jelly in rat skin wounds
ArticleAbstract: Growth factors have proved to be an effective therapeutic strategy. However, some controversies havePalabras claves:125 I-rhEGF, Jelly, Non-linearity, Strength, Topical dispositionAutores:Aguilera A., Alfonso-Ortíz S., Alvarez D., Bécquer M.d.l.A., Duconge J., Estrada L., Eugenio Hardy, Fernández-Sánchez E.M., García-Pulpeiro O., Prats P.A., Rojas I., Valenzuela-Silva C.M.Fuentes:scopus